These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 33854696)
1. RIPK3 Induces Cardiomyocyte Necroptosis via Inhibition of AMPK-Parkin-Mitophagy in Cardiac Remodelling after Myocardial Infarction. Zhu P; Wan K; Yin M; Hu P; Que Y; Zhou X; Zhang L; Li T; Du Y; Xu G; Fang X Oxid Med Cell Longev; 2021; 2021():6635955. PubMed ID: 33854696 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-325-3p protects the heart after myocardial infarction by inhibiting RIPK3 and programmed necrosis in mice. Zhang DY; Wang BJ; Ma M; Yu K; Zhang Q; Zhang XW BMC Mol Biol; 2019 Jun; 20(1):17. PubMed ID: 31248365 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfusion injury. Zhou H; Li D; Zhu P; Ma Q; Toan S; Wang J; Hu S; Chen Y; Zhang Y J Pineal Res; 2018 Oct; 65(3):e12503. PubMed ID: 29770487 [TBL] [Abstract][Full Text] [Related]
4. Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway. Zhu P; Hu S; Jin Q; Li D; Tian F; Toan S; Li Y; Zhou H; Chen Y Redox Biol; 2018 Jun; 16():157-168. PubMed ID: 29502045 [TBL] [Abstract][Full Text] [Related]
5. Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction. Zhang H; Yin Y; Liu Y; Zou G; Huang H; Qian P; Zhang G; Zhang J Biochem Pharmacol; 2020 May; 175():113915. PubMed ID: 32179044 [TBL] [Abstract][Full Text] [Related]
6. Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy. Guan Z; Chen J; Wang L; Hao M; Dong X; Luo T; Jiang J; Lin Z; Li X; Chen P; Yang Z; Ye X; Wang L; Xian S; Chen Z Phytomedicine; 2023 Jan; 108():154494. PubMed ID: 36279758 [TBL] [Abstract][Full Text] [Related]
7. Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury. Zhou H; Zhu P; Guo J; Hu N; Wang S; Li D; Hu S; Ren J; Cao F; Chen Y Redox Biol; 2017 Oct; 13():498-507. PubMed ID: 28732308 [TBL] [Abstract][Full Text] [Related]
8. Ripk3 mediates cardiomyocyte necrosis through targeting mitochondria and the JNK-Bnip3 pathway under hypoxia-reoxygenation injury. Song X; Li T J Recept Signal Transduct Res; 2019 Aug; 39(4):331-340. PubMed ID: 31658855 [No Abstract] [Full Text] [Related]
9. Dapagliflozin Alleviates Myocardial Ischaemia Reperfusion Injury by Activating Mitophagy Zuo W; Wang L; Tian R; Wang L; Liu Y; Qian H; Yang X; Liu Z Curr Vasc Pharmacol; 2024; 22(3):203-217. PubMed ID: 38141195 [TBL] [Abstract][Full Text] [Related]
10. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Luedde M; Lutz M; Carter N; Sosna J; Jacoby C; Vucur M; Gautheron J; Roderburg C; Borg N; Reisinger F; Hippe HJ; Linkermann A; Wolf MJ; Rose-John S; Lüllmann-Rauch R; Adam D; Flögel U; Heikenwalder M; Luedde T; Frey N Cardiovasc Res; 2014 Jul; 103(2):206-16. PubMed ID: 24920296 [TBL] [Abstract][Full Text] [Related]
11. Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D. Sun T; Ding W; Xu T; Ao X; Yu T; Li M; Liu Y; Zhang X; Hou L; Wang J Antioxid Redox Signal; 2019 Dec; 31(16):1177-1193. PubMed ID: 31456416 [No Abstract] [Full Text] [Related]
12. COP9 Signalosome Suppresses RIPK1-RIPK3-Mediated Cardiomyocyte Necroptosis in Mice. Xiao P; Wang C; Li J; Su H; Yang L; Wu P; Lewno MT; Liu J; Wang X Circ Heart Fail; 2020 Aug; 13(8):e006996. PubMed ID: 32578441 [TBL] [Abstract][Full Text] [Related]
13. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction. Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597 [TBL] [Abstract][Full Text] [Related]
14. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction. Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485 [TBL] [Abstract][Full Text] [Related]
15. The AMPK-Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome. Lee SB; Kim JJ; Han SA; Fan Y; Guo LS; Aziz K; Nowsheen S; Kim SS; Park SY; Luo Q; Chung JO; Choi SI; Aziz A; Yin P; Tong SY; Fiesel FC; Springer W; Zhang JS; Lou Z Nat Cell Biol; 2019 Aug; 21(8):940-951. PubMed ID: 31358971 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction. Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847 [TBL] [Abstract][Full Text] [Related]
17. Xinyang tablet alleviated cardiac dysfunction in a cardiac pressure overload model by regulating the receptor-interacting serum/three-protein kinase 3/FUN14 domain containing 1-mediated mitochondrial unfolded protein response and mitophagy. Dong X; Zhuang HW; Wen RJ; Huang YS; Liang BX; Li H; Xian SX; Li C; Wang LJ; Wang JY J Ethnopharmacol; 2024 Aug; 330():118152. PubMed ID: 38614260 [TBL] [Abstract][Full Text] [Related]
18. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877 [TBL] [Abstract][Full Text] [Related]
19. Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy. Zhou J; Wang Z; He Y; Luo X; Zhang W; Yu L; Chen X; He X; Yuan Y; Wang X; Guo X; Tang J; Zhu M; Li D; Ding Y BMC Complement Med Ther; 2020 Jul; 20(1):203. PubMed ID: 32615967 [TBL] [Abstract][Full Text] [Related]
20. Ca Hua Y; Qian J; Cao J; Wang X; Zhang W; Zhang J Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]